-
April 18: The Week in Cancer News
Gaps in goals-of-care discussions may harm young adults with cancer, and 1 in 6 participants in phase II trials get treatments that are eventually approved by the FDA.
by Marci A. Landsmann
-
April 11: The Week in Cancer News
NIH layoffs delay research benefiting cancer patients, and celebrity cancer news is often missing important information.
by Kevin McLaughlin
-
Melanoma Risk in Childhood Cancer Survivors
People treated for childhood cancer found to have twice the risk of developing melanoma as an adult.
by Cameron Walker
-
April 4: The Week in Cancer News
Some early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.
by Eric Fitzsimmons
-
Online Second Opinions
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
-
March 28: The Week in Cancer News
New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.
by Thomas Celona
-
Musical Toxicity an Effect of Cancer Treatment
Study finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
-
March 21: The Week in Cancer News
Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
by Marci A. Landsmann
-
Treatment Lags Behind Guidelines for Many Men With Prostate Cancer
Guidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona